IRAK1 and Alzheimer disease: In the neuroinflammatory process, IRAK4 and IRAK1, as downstream signaling components of TLRs and IL-1s, are crucial and the inhibition of IRAK1/4 was revealed to reduce neuroinflammation and present potential as a new target for AD [49,50].